NEW YORK (GenomeWeb News) – OncoMethylome Sciences today reported fiscal 2008 revenue growth of 15 percent and a 2 percent increase in its net loss year over year.

The Liege, Belgium-based firm brought in total revenues of €3 million ($3.9 million) for 2008, up from revenues of €2.6 million for 2007. OncoMethylome said the increase was due to new products and collbaorations with pharmaceutical companies.

Its net loss for the year was €10.2 million, or €.77 per share, compared to a net loss of €10 million, or €.85 per share, for 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."